BACKGROUND: Congenital hereditary endothelial dystrophy (CHED) is a corneal dystrophy characterised by diffuse bilateral corneal clouding resulting in impaired vision. It is inherited in either an autosomal dominant (AD) or autosomal recessive (AR) manner. The AD form of CHED has been mapped to the pericentromeric region of chromosome 20. Another endothelial dystrophy, posterior polymorphous dystrophy (PPM), has been linked to a larger but overlapping region on chromosome 20. A large, Irish, consanguineous family with AR CHED was investigated to determine if there was linkage to this region. METHODS: The technique of linkage analysis with polymorphic microsatellite markers amplified by polymerase chain reaction (PCR) was used. In addition, a DNA pooling approach to homozygosity mapping was employed to demonstrate the efficiency of this method. RESULTS: Conventional genetic analysis in addition to a pooled DNA strategy excludes linkage of AR CHED to the AD CHED and larger PPMD loci. CONCLUSION: This demonstrates that AR CHED is genetically distinct from AD CHED and PPMD.
BACKGROUND:Congenital hereditary endothelial dystrophy (CHED) is a corneal dystrophy characterised by diffuse bilateral corneal clouding resulting in impaired vision. It is inherited in either an autosomal dominant (AD) or autosomal recessive (AR) manner. The AD form of CHED has been mapped to the pericentromeric region of chromosome 20. Another endothelial dystrophy, posterior polymorphous dystrophy (PPM), has been linked to a larger but overlapping region on chromosome 20. A large, Irish, consanguineous family with AR CHED was investigated to determine if there was linkage to this region. METHODS: The technique of linkage analysis with polymorphic microsatellite markers amplified by polymerase chain reaction (PCR) was used. In addition, a DNA pooling approach to homozygosity mapping was employed to demonstrate the efficiency of this method. RESULTS: Conventional genetic analysis in addition to a pooled DNA strategy excludes linkage of AR CHED to the AD CHED and larger PPMD loci. CONCLUSION: This demonstrates that AR CHED is genetically distinct from AD CHED and PPMD.
Authors: E Pras; I Aksentijevich; L Gruberg; J E Balow; L Prosen; M Dean; A D Steinberg; M Pras; D L Kastner Journal: N Engl J Med Date: 1992-06-04 Impact factor: 91.245
Authors: V C Sheffield; R Carmi; A Kwitek-Black; T Rokhlina; D Nishimura; G M Duyk; K Elbedour; S L Sunden; E M Stone Journal: Hum Mol Genet Date: 1994-08 Impact factor: 6.150
Authors: D Hillaire; A Leclerc; S Fauré; H Topaloglu; N Chiannilkulchaï; P Guicheney; L Grinas; P Legos; J Philpot; T Evangelista Journal: Hum Mol Genet Date: 1994-09 Impact factor: 6.150
Authors: C Ben Hamida; N Doerflinger; S Belal; C Linder; L Reutenauer; C Dib; G Gyapay; A Vignal; D Le Paslier; D Cohen Journal: Nat Genet Date: 1993-10 Impact factor: 38.330
Authors: Jayne S Weiss; H U Møller; Walter Lisch; Shigeru Kinoshita; Anthony J Aldave; Michael W Belin; Tero Kivelä; Massimo Busin; Francis L Munier; Berthold Seitz; John Sutphin; Cecilie Bredrup; Mark J Mannis; Christopher J Rapuano; Gabriel Van Rij; Eung Kweon Kim; Gordon K Klintworth Journal: Cornea Date: 2008-12 Impact factor: 2.651
Authors: Salina Siddiqui; Juan Carlos Zenteno; Aine Rice; Oscar Chacón-Camacho; Steven G Naylor; David Rivera-de la Parra; David M Spokes; Nigel James; Carmel Toomes; Chris F Inglehearn; Manir Ali Journal: Cornea Date: 2014-03 Impact factor: 2.651